Recent clinical practice guidelines recommend to avoid “diabetes overtreatment” in older people living with type 2 diabetes (T2D), conceptually corresponding to an inappropriate level of glycemia that places the patient at high risk of unwanted side effects of glucose-lowering treatment (e.g., hypoglycemia), without providing a clinically implementable definition of this concept (1,2).